한글목차

세계의 구강암 신속 검사 키트 시장은 2024년에 10억 1,259만 달러로 평가되었으며, 2030년까지 CAGR 4.3%로 성장하여 13억 359만 달러에 달할 것으로 예측됩니다.

구강암 신속 검사 키트는 잠재적 구강암 환자를 신속하게 식별하기 위해 고안된 비침습적 진단 도구로, 주로 진료 현장(Point of Care)에서 조기 발견을 촉진하기 위해 채택되고 있습니다. 시장 확대는 기본적으로 전 세계 구강암 발생률의 증가와 조기 진단 및 정기적인 검진 프로그램의 이점에 대한 인식이 높아짐에 따라 촉진되고 있습니다.

주요 시장 촉진요인

전 세계적으로 구강암의 급속한 증가가 구강암 신속 검사 키트 시장을 근본적으로 견인하고 있으며, 접근하기 쉽고 효율적인 진단 도구가 필요하게 되었습니다. 구강암은 진행된 상태에서 발견되는 경우가 많아 예후가 좋지 않기 때문에 조기 발견이 환자의 예후를 개선하는 데 매우 중요합니다.

주요 시장 과제

구강암의 위험 요인, 조기 발견의 중요성, 신속 검사 옵션의 가용성에 대한 일반인 및 전문가들의 인식이 제한적이라는 점이 세계 구강암 신속 검사 키트 시장의 성장을 저해하는 요인으로 작용하고 있습니다. 이 문제는 이러한 진단 도구의 도입과 활용을 직접적으로 제한하고 있습니다.

주요 시장 동향

재택 검사 솔루션의 확대는 중요한 추세로, 기존의 임상 환경을 넘어 구강암 검진에 대한 접근성을 확대하고 있습니다. 이러한 추세는 개인이 프라이빗하고 효율적으로 예비검사를 실시할 수 있는 편리한 진단 도구에 대한 수요에 부응하는 것입니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 구강암 신속 검사 키트 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 종류별(온크얼트 구강암 검사실, 랩 온 칩, 인실릭사 검사, 프레보-체크)
  • 최종사용자별(병원·진료소, 외래 진료 센터, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 구강암 신속 검사 키트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 구강암 신속 검사 키트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 구강암 신속 검사 키트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 구강암 신속 검사 키트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 구강암 신속 검사 키트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 구강암 신속 검사 키트 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche AG
• Beckman Coulter, Inc.
• Becton, Dickinson and Co.
• Bio-Rad Laboratories, Inc.
• Danaher Corp.
• GRAIL, LLC
• Henry Schein, Inc.
• Quest Diagnostics Inc.
• Quidel Corp.
• Siemens Healthineers AG
• Trinity Biotech plc
• Viome Life Sciences, Inc.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Oral Cancer Rapid Test Kit Market, valued at USD 1012.59 Million in 2024, is projected to experience a CAGR of 4.3% to reach USD 1303.59 Million by 2030. Oral Cancer Rapid Test Kits are non-invasive diagnostic tools designed for the swift identification of potential oral cancer cases, primarily employed in point-of-care settings to facilitate early detection. The market's expansion is fundamentally driven by the escalating global incidence of oral cancer and increasing awareness regarding the benefits of early diagnosis and regular screening programs.

Key Market Drivers

The escalating global incidence of oral cancer fundamentally drives the Oral Cancer Rapid Test Kit Market, necessitating accessible and efficient diagnostic tools. Early detection is critical for improving patient outcomes, as oral cancer often presents in advanced stages with poorer prognoses. For example, according to Cancer Research UK, in 2022, there were 389,846 new cases of mouth and oral cancer globally. This substantial annual caseload underscores the urgent need for widespread early screening. Rapid test kits are ideally positioned to meet this demand, enabling timely identification in diverse healthcare settings and facilitating prompt intervention. The rising global prevalence of oral cancer sustains the imperative for proactive screening measures that these rapid diagnostic solutions can effectively support.

Key Market Challenges

The limited public and professional awareness regarding oral cancer risk factors, the importance of early detection, and the availability of rapid testing options significantly impedes the growth of the Global Oral Cancer Rapid Test Kit Market. This challenge directly restricts the adoption and utilization of these diagnostic tools. When both the general public and healthcare professionals lack comprehensive education on oral cancer's subtle initial signs and the critical benefits of early screening, the demand for rapid test kits remains subdued.

Key Market Trends

The expansion of at-home testing solutions represents a pivotal trend, broadening access to oral cancer screening beyond traditional clinical settings. This trend addresses the demand for convenient diagnostic tools, empowering individuals to undertake preliminary screening privately and efficiently. For example, the U. S. Centers for Disease Control and Prevention reported that cancer screening rates declined by 15-2% since 2020, highlighting the substantial need for accessible home-based alternatives.

Key Market Players

• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche AG
• Beckman Coulter, Inc.
• Becton, Dickinson and Co.
• Bio-Rad Laboratories, Inc.
• Danaher Corp.
• GRAIL, LLC
• Henry Schein, Inc.
• Quest Diagnostics Inc.
• Quidel Corp.
• Siemens Healthineers AG
• Trinity Biotech plc
• Viome Life Sciences, Inc.

Report Scope:

In this report, the Global Oral Cancer Rapid Test Kit Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Cancer Rapid Test Kit Market, By Type:

• Onc Alert Oral Cancer LAB
• Lab on Chip
• Insilixa Test
• Prevo- Check

Oral Cancer Rapid Test Kit Market, By End user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Oral Cancer Rapid Test Kit Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Cancer Rapid Test Kit Market.

Available Customizations:

Global Oral Cancer Rapid Test Kit Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Cancer Rapid Test Kit Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Onc Alert Oral Cancer LAB, Lab on Chip, Insilixa Test, Prevo- Check)
  • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Oral Cancer Rapid Test Kit Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End user
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oral Cancer Rapid Test Kit Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End user
  • 6.3.2. Canada Oral Cancer Rapid Test Kit Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End user
  • 6.3.3. Mexico Oral Cancer Rapid Test Kit Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End user

7. Europe Oral Cancer Rapid Test Kit Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End user
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oral Cancer Rapid Test Kit Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End user
  • 7.3.2. France Oral Cancer Rapid Test Kit Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End user
  • 7.3.3. United Kingdom Oral Cancer Rapid Test Kit Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End user
  • 7.3.4. Italy Oral Cancer Rapid Test Kit Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End user
  • 7.3.5. Spain Oral Cancer Rapid Test Kit Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End user

8. Asia Pacific Oral Cancer Rapid Test Kit Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End user
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Oral Cancer Rapid Test Kit Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End user
  • 8.3.2. India Oral Cancer Rapid Test Kit Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End user
  • 8.3.3. Japan Oral Cancer Rapid Test Kit Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End user
  • 8.3.4. South Korea Oral Cancer Rapid Test Kit Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End user
  • 8.3.5. Australia Oral Cancer Rapid Test Kit Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End user

9. Middle East & Africa Oral Cancer Rapid Test Kit Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End user
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Oral Cancer Rapid Test Kit Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End user
  • 9.3.2. UAE Oral Cancer Rapid Test Kit Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End user
  • 9.3.3. South Africa Oral Cancer Rapid Test Kit Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End user

10. South America Oral Cancer Rapid Test Kit Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End user
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Oral Cancer Rapid Test Kit Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End user
  • 10.3.2. Colombia Oral Cancer Rapid Test Kit Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End user
  • 10.3.3. Argentina Oral Cancer Rapid Test Kit Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Oral Cancer Rapid Test Kit Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. F. Hoffmann-La Roche AG
• 15.4. Beckman Coulter, Inc.
• 15.5. Becton, Dickinson and Co.
• 15.6. Bio-Rad Laboratories, Inc.
• 15.7. Danaher Corp.
• 15.8. GRAIL, LLC
• 15.9. Henry Schein, Inc.
• 15.10. Quest Diagnostics Inc.
• 15.11. Quidel Corp.
• 15.12. Siemens Healthineers AG
• 15.13. Trinity Biotech plc
• 15.14. Viome Life Sciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer